as 04-03-2025 4:00pm EST
Founded: | 2014 | Country: | Hong Kong |
Employees: | N/A | City: | N/A |
Market Cap: | N/A | IPO Year: | 2021 |
Target Price: | N/A | AVG Volume (30 days): | 2.0M |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.33 | EPS Growth: | N/A |
52 Week Low/High: | $3.03 - $69.00 | Next Earning Date: | 10-25-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
RGC Breaking Stock News: Dive into RGC Ticker-Specific Updates for Smart Investing
Insider Monkey
14 days ago
MT Newswires
17 days ago
Insider Monkey
18 days ago
Simply Wall St.
19 days ago
Simply Wall St.
20 days ago
Simply Wall St.
5 months ago
Simply Wall St.
8 months ago
PR Newswire
a year ago
The information presented on this page, "RGC Regencell Bioscience Holdings Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.